Computed Tomography (CT) Colonography Versus Optical Colonoscopy
Launched by UNIVERSITY OF BRITISH COLUMBIA · Aug 12, 2010
Trial Information
Current as of June 25, 2025
Unknown status
Keywords
ClinConnect Summary
1. Purpose To study the Effect of Experience and Training on the Accuracy of CT (Computed Tomography) Colonography in Comparison with Optical Colonoscopy in the Detection of Colonic Neoplasia
2. Hypotheses
1. The accuracy (sensitivity and specificity) of interpretation of the CTC images will improve with each 100 scans examined. Less time will be required to interpret the CTC images after each successive 100 scans. The accuracy of each of the observers will be similar.
2. The sensitivity and specificity will be similar for CTC and OC for the last 100 patients undergoing both examinations....
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 19 - 65 years of age
- • Have a recognized indication for optical colonoscopy, including high risk for colorectal cancer
- • Over 45 years of age with a family history of colorectal cancer, those with positive screening tests (FOBT, DRE, flexible sigmoidoscopy and contrast enema)
- • Previous history of advanced adenomas and those with suggestive symptoms and signs (bleeding, abdominal pain, anemia)
- • Must be able to read and understand English and must be able to give informed consent
About University Of British Columbia
The University of British Columbia (UBC) is a leading research institution located in Vancouver, Canada, renowned for its commitment to advancing health sciences through innovative research and education. As a prominent clinical trial sponsor, UBC leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes across various medical fields. The university fosters collaborations with healthcare professionals, industry partners, and community stakeholders to translate research findings into practical applications, thereby contributing to the global advancement of medicine and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vancouver, British Columbia, Canada
Vancouver, British Columbia, Canada
Patients applied
Trial Officials
Robert Enns, Dr.
Principal Investigator
University of British Columbia
Jacquie Brown, Dr.
Study Director
University of British Columbia
Jennifer Telford, Dr.
Study Director
University of British Columbia
Gregory Rosenfeld, Dr.
Study Director
University of British Columbia
Pari Tiwari, Dr.
Study Director
University of British Columbia
Darin Krygier, Dr.
Study Director
University of British Columbia
Brian Bressler, Dr.
Study Director
University of British Columbia
Patrick Vos, Dr.
Study Director
University of British Columbia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials